RESTON, Va., May 22, 2025 (GLOBE NEWSWIRE) -- Bowman Consulting Group Ltd.

Calavo Growers to Report Second Quarter 2025 Financial Results — Neutral
CVGW GlobeNewsWire — May 22, 2025SANTA PAULA, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Calavo Growers, Inc. (Nasdaq-GS: CVGW), a global leader in the processing and distribution of avocados, tomatoes, papayas, and guacamole, today announced that it plans to release financial results for the fiscal second quarter ended April 30, 2025, after the market closes on Monday, June 9, 2025.

US Data Centers Inc., a Subsidiary of Digi Power X, to Collaborate With Super Micro for Initial Deployment of Customized B200 GPU Infrastructure — Neutral
DGXX SMCI GlobeNewsWire — May 22, 2025MIAMI, May 22, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), a vertically integrated power infrastructure company focused on developing cutting-edge data centers for high-performance computing, is pleased to announce that US Data Centers, Inc., a wholly owned subsidiary of the Company, has entered into a collaboration with Super Micro Computer, Inc. (NASDAQ: SMCI) to deploy customized B200 GPU rack solutions at the Company's newly developed data center in Alabama. The collaboration will begin with an initial deployment targeting operational readiness within 120 days, with full test operations expected …

Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) — Neutral
MDCX Newsfile Corp — May 22, 2025The Clinical Study Is Expected to Randomize 36 Participants in Cleveland Clinic Abu Dhabi (CCAD) and Three Other Clinical Sites in UAE Philadelphia, Pennsylvania--(Newsfile Corp. - May 22, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce that it has received study may proceed approval from the UAE DOH to commence Phase 2 clinical study (SKNJCT-004) to non-invasively treat BCC of the skin.

Graphic Packaging Holding Company Declares Quarterly Dividend — Neutral
GPK PRNewsWire — May 22, 2025ATLANTA , May 22, 2025 /PRNewswire/ -- Graphic Packaging Holding Company (NYSE: GPK), a global leader in sustainable consumer packaging, today announced that its Board of Directors declared a quarterly dividend of $0.11 per share of common stock to stockholders of record at the close of business on June 15, 2025. The dividend is payable on July 5, 2025.

Income Strikes Back: 3 Must-Own Dividend Stocks For What's Coming — Positive
NEE NTST PEP Seeking Alpha — May 22, 2025I believe stocks are superior to bonds long term, especially during inflationary periods. But recent trends suggest bonds are becoming more competitive. Higher bond yields and rising stock valuations have made the risk/reward balance less favorable for stocks, especially defensive, income-oriented ones. I'm not buying bonds, but I see big opportunities in high-quality dividend stocks that have fallen out of favor, but still offer strong long-term growth.

GRAND RAPIDS, Mich. , May 22, 2025 /PRNewswire/ -- Food solutions company SpartanNash® (the "Company") (Nasdaq: SPTN) today announced that on May 21, 2025, its Board of Directors approved a quarterly cash dividend of $0.22 per common share.

Lantheus Holdings, Inc. (LNTH) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights — Neutral
LNTH Accesswire — May 22, 2025NEW YORK, NY / ACCESS Newswire / May 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Lantheus Holdings, Inc. ("Lantheus Holdings, Inc.") (NASDAQ:LNTH) concerning possible violations of federal securities laws. On May 7, 2025, Lantheus reported its financial results for the first quarter of 2025.

nCino, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - NCNO — Neutral
NCNO Accesswire — May 22, 2025NEW YORK, NY / ACCESS Newswire / May 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of nCino, Inc. ("nCino, Inc.") (NASDAQ:NCNO) concerning possible violations of federal securities laws. On April 1, 2025, nCino reported positive 4Q 2025 financial results but announced fiscal 2026 guidance that was below analysts' expectations.

LEGN ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Legend Biotech Corporation Shareholders Who Lost Money — Neutral
LEGN Accesswire — May 22, 2025NEW YORK, NY / ACCESS Newswire / May 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws. On May 13, 2024, Legend published first quarter financial results and business updates, including, among other things, news that the Company is navigating regulatory challenges, such as the need for FDA approval for the expansion of its Raritan manufacturing facility.

Applied Materials to Participate in Upcoming Investor Conferences — Neutral
AMAT GlobeNewsWire — May 22, 2025SANTA CLARA, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that members of management will participate in fireside chats at upcoming investor conferences.

Cytokinetics, Incorporated (CYTK) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates — Neutral
CYTK Accesswire — May 22, 2025NEW YORK, NY / ACCESS Newswire / May 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) concerning possible violations of federal securities laws. BioPharma Dive published a report on Cytokinetics on May 2, 2025, and stated that, "The Food and Drug Administration has delayed an approval decision on Cytokinetics' experimental hypertrophic obstructive cardiomyopathy drug aficamten so it can have more time to review the company's proposed risk management plan.

VSTS ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Vestis Corporation — Neutral
VSTS Accesswire — May 22, 2025NEW YORK, NY / ACCESS Newswire / May 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vestis Corporation ("Vestis Corporation") (NYSE:VSTS) concerning possible violations of federal securities laws. On May 6, 2025, Vestis reported a significant drop in 2Q 2025 revenue results that missed analysts' expectations.

Informatica Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - INFA — Neutral
INFA Accesswire — May 22, 2025NEW YORK, NY / ACCESS Newswire / May 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Informatica Inc. ("Informatica Inc.") (NYSE:INFA) concerning possible violations of federal securities laws. On February 13, 2025, Informatica issued a press release announcing its fourth quarter 2024 financial results, missing revenue forecasts and issuing disappointing fiscal 2025 guidance on the back of disappointing renewal rates.

Quantum-Si: Sell On Weak Prospects And Risk Of Further Dilution — Neutral
QSI Seeking Alpha — May 22, 2025After mistakenly having been picked up as a quantum computing play in late 2024, shares of life sciences company, Quantum-Si, have given back most of their gains in recent months. While the company used the hype to replenish its dwindling cash balances, dilution for common shareholders has been substantial. Quantum-Si remains years behind its original business plan with an inflection point nowhere in sight. The company continues to burn substantial amounts of cash.

Soluna to Launch First Solar-Powered Data Center With 75 MW Project — Neutral
SLNH Business Wire — May 22, 2025ALBANY, N.Y.--(BUSINESS WIRE)---- $SLNH #SLNH--Soluna Holdings, Inc. (“Soluna” or the “Company”), (NASDAQ: SLNH), a developer of green data centers for intensive computing applications, including Bitcoin mining and AI, announced today that it has signed a term sheet for power for Project Annie, a new 75 MW data center co-located with a 114 MW solar farm in northeast Texas. Project Annie marks Soluna's first solar-powered deployment, representing a strategic expansion of the Company's modular computing platform.

nVent Electric plc to Participate in the William Blair Growth Stock Conference — Neutral
NVT Business Wire — May 22, 2025LONDON--(BUSINESS WIRE)--nVent (NYSE: NVT), a global leader in electrical connection and protection solutions, will participate in the William Blair Growth Stock Conference on Thursday, June 5, 2025. Beth Wozniak, Chair and Chief Executive Officer, will present at 9:20 a.m. CT. A webcast will be available on nVent's Investor Relations website at https://investors.nvent.com/events-and-presentations. About nVent nVent is a leading global provider of electrical connection and protection solutions.

Redwire Awarded Contract to Provide Critical Avionics Technology for Multinational Earth Observation Satellite Constellation — Neutral
RDW Business Wire — May 22, 2025JACKSONVILLE, Fla.--(BUSINESS WIRE)---- $RDW--Redwire Corporation (NYSE:RDW), a leader in space infrastructure for the next generation space economy, announced today that it has been awarded a contract by SpaceTech GmbH to provide critical avionics technology for the European Space Agency's (ESA) Next Generation Gravity Mission (NGGM) satellites. The NGGM satellites are ESA's contribution to a planned NASA and ESA Earth observation satellite constellation known as Mass Change and Geophysics Internationa.

JENA, Germany, May 22, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will participate in multiple investor conferences in June and July 2025.

scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025 — Neutral
SCPH Seeking Alpha — May 22, 2025Shares of scPharmaceuticals have lost 37% over the past 3 years and are down 11% in 2025. Furoscix's subcutaneous administration offers the potential to keep heart failure patients at home longer and cut down on hospital readmissions. Q1 seasonality is in the rearview mirror, with multiple tailwinds, including Medicare redesign and label expansion, to fuel growth going forward.
